Merus NVNASDAQ:MRUS
- LAST PRICE43.9100
- TODAY'S CHANGE (%)-1.1100 (-2.4656%)
- Bid / Lots42.0400/ 1
- Ask / Lots48.4300/ 1
- Open / Previous Close45.0600 / 45.0200
- Day Range
- 52 Week Range
- Volume486,819
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MRUS |
|---|---|---|
| 09:32 ET | 1594 | 45.01 |
| 09:38 ET | 1000 | 44.99 |
| 09:41 ET | 1500 | 44.8 |
| 09:43 ET | 900 | 44.79 |
| 09:45 ET | 841 | 44.795 |
| 09:48 ET | 300 | 44.795 |
| 09:50 ET | 100 | 44.785 |
| 09:52 ET | 150 | 44.92 |
| 09:54 ET | 2065 | 44.58 |
| 09:56 ET | 3800 | 44.5201 |
| 09:57 ET | 3108 | 44.325 |
| 09:59 ET | 13783 | 44.42 |
| 10:01 ET | 406 | 44.45 |
| 10:03 ET | 700 | 44.625 |
| 10:06 ET | 309 | 44.63 |
| 10:08 ET | 3197 | 45.015 |
| 10:10 ET | 2199 | 44.99 |
| 10:12 ET | 3963 | 45.04 |
| 10:14 ET | 6639 | 44.86 |
| 10:15 ET | 900 | 44.885 |
| 10:17 ET | 2100 | 44.83 |
| 10:19 ET | 9071 | 44.73 |
| 10:21 ET | 934 | 44.66 |
| 10:24 ET | 1850 | 44.93 |
| 10:26 ET | 6227 | 45.03 |
| 10:28 ET | 4329 | 44.94 |
| 10:30 ET | 510 | 44.94 |
| 10:32 ET | 1221 | 44.95 |
| 10:33 ET | 700 | 44.94 |
| 10:35 ET | 1895 | 44.82 |
| 10:37 ET | 1130 | 44.67 |
| 10:44 ET | 200 | 44.645 |
| 10:46 ET | 1010 | 44.67 |
| 10:48 ET | 800 | 44.71 |
| 10:50 ET | 300 | 44.72 |
| 10:51 ET | 200 | 44.725 |
| 10:53 ET | 1100 | 44.74 |
| 10:55 ET | 400 | 44.725 |
| 10:57 ET | 1300 | 44.72 |
| 11:00 ET | 200 | 44.72 |
| 11:02 ET | 400 | 44.72 |
| 11:04 ET | 1400 | 44.69 |
| 11:06 ET | 100 | 44.69 |
| 11:08 ET | 400 | 44.69 |
| 11:09 ET | 1118 | 44.65 |
| 11:11 ET | 100 | 44.63 |
| 11:13 ET | 200 | 44.65 |
| 11:15 ET | 600 | 44.655 |
| 11:18 ET | 400 | 44.655 |
| 11:20 ET | 400 | 44.65 |
| 11:22 ET | 743 | 44.65 |
| 11:24 ET | 1756 | 44.71 |
| 11:26 ET | 400 | 44.71 |
| 11:27 ET | 901 | 44.82 |
| 11:29 ET | 100 | 44.775 |
| 11:31 ET | 350 | 44.815 |
| 11:33 ET | 600 | 44.76 |
| 11:36 ET | 1777 | 44.6 |
| 11:38 ET | 2993 | 44.47 |
| 11:40 ET | 100 | 44.47 |
| 11:42 ET | 1700 | 44.44 |
| 11:44 ET | 5492 | 44.38 |
| 11:45 ET | 4834 | 44.445 |
| 11:47 ET | 400 | 44.435 |
| 11:49 ET | 1000 | 44.485 |
| 11:51 ET | 200 | 44.48 |
| 11:54 ET | 200 | 44.46 |
| 11:56 ET | 300 | 44.45 |
| 11:58 ET | 300 | 44.45 |
| 12:00 ET | 200 | 44.45 |
| 12:02 ET | 1800 | 44.515 |
| 12:03 ET | 1303 | 44.47 |
| 12:05 ET | 300 | 44.525 |
| 12:07 ET | 400 | 44.525 |
| 12:09 ET | 2340 | 44.63 |
| 12:14 ET | 1642 | 44.71 |
| 12:16 ET | 500 | 44.71 |
| 12:18 ET | 600 | 44.87 |
| 12:20 ET | 400 | 44.785 |
| 12:21 ET | 1870 | 44.695 |
| 12:23 ET | 811 | 44.67 |
| 12:25 ET | 300 | 44.62 |
| 12:34 ET | 300 | 44.655 |
| 12:36 ET | 600 | 44.69 |
| 12:38 ET | 300 | 44.72 |
| 12:39 ET | 500 | 44.705 |
| 12:41 ET | 500 | 44.715 |
| 12:43 ET | 500 | 44.7 |
| 12:45 ET | 1200 | 44.68 |
| 12:48 ET | 300 | 44.68 |
| 12:50 ET | 600 | 44.63 |
| 12:52 ET | 4952 | 44.45 |
| 12:54 ET | 500 | 44.42 |
| 12:57 ET | 1451 | 44.46 |
| 12:59 ET | 300 | 44.42 |
| 01:01 ET | 2920 | 44.53 |
| 01:03 ET | 400 | 44.5305 |
| 01:06 ET | 200 | 44.565 |
| 01:08 ET | 200 | 44.62 |
| 01:10 ET | 900 | 44.66 |
| 01:12 ET | 600 | 44.66 |
| 01:14 ET | 400 | 44.66 |
| 01:15 ET | 200 | 44.66 |
| 01:17 ET | 200 | 44.645 |
| 01:19 ET | 300 | 44.685 |
| 01:21 ET | 300 | 44.64 |
| 01:24 ET | 300 | 44.68 |
| 01:26 ET | 200 | 44.64 |
| 01:28 ET | 500 | 44.72 |
| 01:30 ET | 600 | 44.71 |
| 01:32 ET | 500 | 44.66 |
| 01:33 ET | 200 | 44.72 |
| 01:35 ET | 900 | 44.65 |
| 01:37 ET | 1700 | 44.62 |
| 01:39 ET | 400 | 44.62 |
| 01:42 ET | 200 | 44.62 |
| 01:44 ET | 100 | 44.62 |
| 01:46 ET | 400 | 44.59 |
| 01:48 ET | 394 | 44.625 |
| 01:50 ET | 300 | 44.66 |
| 01:51 ET | 700 | 44.645 |
| 01:53 ET | 1969 | 44.6 |
| 01:55 ET | 2900 | 44.47 |
| 01:57 ET | 100 | 44.425 |
| 02:00 ET | 1500 | 44.34 |
| 02:02 ET | 1413 | 44.375 |
| 02:04 ET | 400 | 44.35 |
| 02:06 ET | 600 | 44.375 |
| 02:08 ET | 100 | 44.38 |
| 02:09 ET | 100 | 44.42 |
| 02:11 ET | 300 | 44.38 |
| 02:13 ET | 400 | 44.38 |
| 02:15 ET | 3796 | 44.2 |
| 02:18 ET | 950 | 44.2 |
| 02:20 ET | 200 | 44.18 |
| 02:22 ET | 2946 | 44.22 |
| 02:24 ET | 377 | 44.22 |
| 02:27 ET | 1095 | 44.24 |
| 02:29 ET | 200 | 44.24 |
| 02:31 ET | 400 | 44.41 |
| 02:33 ET | 400 | 44.42 |
| 02:36 ET | 1126 | 44.365 |
| 02:38 ET | 4688 | 44.14 |
| 02:40 ET | 100 | 44.06 |
| 02:42 ET | 1912 | 44.2 |
| 02:44 ET | 4164 | 44.25 |
| 02:45 ET | 1200 | 44.06 |
| 02:47 ET | 400 | 44.14 |
| 02:49 ET | 400 | 44.145 |
| 02:51 ET | 400 | 44.21 |
| 02:54 ET | 32124 | 44.07 |
| 02:56 ET | 2168 | 43.975 |
| 02:58 ET | 1000 | 44.05 |
| 03:00 ET | 400 | 43.98 |
| 03:02 ET | 500 | 43.92 |
| 03:03 ET | 1000 | 43.8 |
| 03:05 ET | 1852 | 43.79 |
| 03:07 ET | 600 | 43.795 |
| 03:09 ET | 2200 | 43.895 |
| 03:12 ET | 1300 | 43.895 |
| 03:14 ET | 400 | 43.895 |
| 03:16 ET | 1792 | 43.88 |
| 03:18 ET | 800 | 43.875 |
| 03:20 ET | 1313 | 43.83 |
| 03:21 ET | 4255 | 43.75 |
| 03:23 ET | 1874 | 43.66 |
| 03:25 ET | 200 | 43.625 |
| 03:27 ET | 3000 | 43.78 |
| 03:30 ET | 414 | 43.77 |
| 03:32 ET | 688 | 43.75 |
| 03:34 ET | 1000 | 43.75 |
| 03:36 ET | 1822 | 43.64 |
| 03:38 ET | 25700 | 43.64 |
| 03:39 ET | 2500 | 43.75 |
| 03:41 ET | 3869 | 44.03 |
| 03:43 ET | 4097 | 43.995 |
| 03:45 ET | 3362 | 44.01 |
| 03:48 ET | 2559 | 44.165 |
| 03:50 ET | 6960 | 44.07 |
| 03:52 ET | 9186 | 44.09 |
| 03:54 ET | 12776 | 44.24 |
| 03:56 ET | 9577 | 44.04 |
| 03:57 ET | 10816 | 44.05 |
| 03:59 ET | 11954 | 43.91 |
May 13, 2024
DJ Merus Carcinoma Treatment Awarded US FDA's Breakthrough Therapy Designation, from 8:38AM ET on Monday May 13, 2024 by Dow Jones
8:38AM ET on Monday May 13, 2024 by Dow JonesPetosemtamab granted Breakthrough Therapy Designation by the U.S. FDA, from 8:00AM ET on Monday May 13, 2024 by Dow Jones
8:00AM ET on Monday May 13, 2024 by Dow JonesDJ Merus Price Target Maintained With a $66.00/Share by Needham, from 6:53AM ET on Monday May 13, 2024 by Dow Jones
6:53AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
DJ Merus Price Target Maintained With a $65.00/Share by HC Wainwright & Co., from 7:38AM ET on Thursday May 09, 2024 by Dow Jones
7:38AM ET on Thursday May 09, 2024 by Dow Jones
May 8, 2024
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update, from 4:15PM ET on Wednesday May 08, 2024 by Dow Jones
4:15PM ET on Wednesday May 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Merus NV | 2.6B | -16.1x | --- |
Intellia Therapeutics Inc | 2.5B | -4.9x | --- |
Celldex Therapeutics Inc | 2.5B | -13.4x | --- |
MoonLake Immunotherapeutics | 2.5B | -53.0x | --- |
Recursion Pharmaceuticals Inc | 2.2B | -5.8x | --- |
Janux Therapeutics Inc | 2.4B | -38.5x | --- |
Company Information
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
Contact Information
- Headquarters
- Uppsalalaan 17, 3rd & 4th floorUTRECHT, Netherlands 3584 CT
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Anand Mehra
- President, Chief Executive Officer, Executive Director
- Sven Lundberg
- Chief Financial Officer
- Gregory Perry
- Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
- Peter Silverman
- Chief Medical Officer
- Andrew Joe
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
|---|---|
Revenue (TTM) | $38.3M |
Shares Outstanding | 58.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.05 |
EPS | $-2.72 |
Book Value | $6.16 |
P/E Ratio | -16.1x |
Price/Sales (TTM) | 67.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -434.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
